"Losing 5 to 10 percent or more of body weight can help some women who aren't ovulating regularly achieve normal cycles and ovulation." Adam Evans, MD, Reproductive Endocrinology and Infertility Specialist, University Hospitals Clinical evidence suggests that using GLP-1 therapies for at least 24 weeks can yield optimal results
Aging Cell 2009
This might make the treatment less effective and increase the risk of cancer coming back
Therefore, M3-type cholinergic receptors and GRP receptors are also involved in metformin-induced changes in GLP-1 secretion
This ratio concerns researchers focused on long-term metabolic health, since muscle mass is a primary driver of basal metabolic rate and functional capacity
Preclinical and early clinical studies support their neuroprotective, anti-inflammatory, and synaptic benefits in conditions such as Alzheimer's disease, Parkinson's disease, and multiple sclerosis